Convergence Investment Partners, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Convergence Investment Partners, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$1,169,000
-35.9%
74,357
-32.9%
0.16%
-31.5%
Q1 2018$1,824,000
+13.3%
110,861
+24.4%
0.24%
+10.2%
Q4 2017$1,610,000
-30.2%
89,121
-25.5%
0.22%
-33.9%
Q3 2017$2,308,000
+75.8%
119,602
+7.5%
0.33%
+70.3%
Q2 2017$1,313,000
-13.7%
111,231
-19.9%
0.19%
-10.3%
Q1 2017$1,521,000
+95.8%
138,800
+29.7%
0.21%
+100.0%
Q4 2016$777,000107,0400.11%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders